The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Shovlin Robert J. since 2015.
This trader's CIK number is 1621453.
At the time of last reporting, Shovlin Robert J. was the President, Clinical Services of Neogenomics Inc. (stock ticker symbol NEO).
Also see all insider trading activities at Neogenomics Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2021 | NEO | 0 | $0 | 130,604 | $5,134,043 | 126,958 | $2,368,147 |
| 2020 | NEO | 0 | $0 | 179,449 | $6,132,507 | 179,558 | $1,903,002 |
| 2019 | NEO | 0 | $0 | 411,635 | $8,612,478 | 429,499 | $3,214,620 |
| 2018 | NEO | 0 | $0 | 229,434 | $3,850,407 | 316,666 | $1,437,000 |
| 2015 | NEO | 6,550 | $50,762 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-05-25 | NEO | Option Ex | 126,958 | 18.65 | 2,368,147 |
| 2021-05-25 | NEO | Sale | 130,604 | 39.31 | 5,134,043 |
| 2020-07-30 | NEO | Option Ex | 83,391 | 13.56 | 1,130,781 |
| 2020-07-30 | NEO | Sale | 81,356 | 38.17 | 3,105,358 |
| 2020-03-04 | NEO | Sale | 98,093 | 30.86 | 3,027,149 |
| 2020-03-04 | NEO | Option Ex | 96,167 | 8.03 | 772,221 |
| 2019-10-31 | NEO | Option Ex | 96,166 | 8.03 | 772,212 |
| 2019-11-01 | NEO | Sale | 35,801 | 22.74 | 814,114 |
| 2019-10-31 | NEO | Sale | 70,473 | 23.11 | 1,628,631 |
| 2019-05-02 | NEO | Option Ex | 133,333 | 7.33 | 977,997 |
| 2019-05-02 | NEO | Sale | 119,347 | 22.14 | 2,642,342 |
| 2019-02-27 | NEO | Sale | 44,135 | 19.23 | 848,716 |
| 2019-02-26 | NEO | Option Ex | 186,014 | 7.33 | 1,364,412 |
| 2019-02-26 | NEO | Sale | 141,879 | 18.88 | 2,678,675 |
| 2019-02-28 | NEO | Option Ex | 13,986 | 7.15 | 99,999 |
| 2018-11-09 | NEO | Sale | 180,000 | 17.05 | 3,069,000 |
| 2018-11-09 | NEO | Option Ex | 300,000 | 4.79 | 1,437,000 |
| 2018-11-12 | NEO | Sale | 36,493 | 16.76 | 611,622 |
| 2018-06-29 | NEO | Sale | 12,941 | 13.12 | 169,785 |
| 2018-05-25 | NEO | Option Ex | 16,666 | .00 | 0 |
| 2015-12-03 | NEO | Buy | 6,550 | 7.75 | 50,762 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Shovlin Robert J. (President, Clinical Services of Neogenomics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.